Publications dans lesquelles il/elle collabore avec ANA Mª GONZÁLEZ-PINTO ARRILLAGA (24)

2024

  1. Analysis of health services use and clinical profiles in the year prior to suicide between 2010 and 2018: An opportunity to improve its prevention

    Spanish Journal of Psychiatry and Mental Health

  2. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  2. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

2021

  1. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms

    Frontiers in Psychiatry, Vol. 12

  2. Gender-Based Analysis of the Psychological Impact of the COVID-19 Pandemic on Healthcare Workers in Spain

    Frontiers in Psychiatry, Vol. 12

  3. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  4. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  3. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

  4. Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment

    Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267

2017

  1. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

    Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577

  2. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

  3. Relationship between the use of benzodiazepines and falls in older adults: A systematic review

    Maturitas, Vol. 101, pp. 17-22

  4. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90